Method of treating irritable bowel syndrome with diarrhoea

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and aims at treating irritable bowel syndrome with diarrhoea. What is used is a low-mineralised sodium hydrocarbonate Abalakhskaya mineral water (AMW) with an faintly alkaline reaction of aqueous medium. The complex therapeutic course makes 21 days including drinking therapy - 18 days, a single drinking dose of AMW of temperature 38-40C is gradually increased from 50-80 ml to 180-200 ml; the procedures of duodenal drainage are performed with the use of AMW of temperature 37-38C in the amount of 200 ml of a single dose; for the procedures of intestinal irrigations, AMW is pre-heated to 40-42C, while a single dose makes 500 ml gradually increased to 800 ml; the procedures of intestinal irrigations are alternated with baths.

EFFECT: method provides higher clinical effectiveness in irritable bowel syndrome, normalised intestinal motility.

2 ex

 

The invention relates to medicine, namely to gastroenterology and balneology, in particular, to methods for treating irritable bowel syndrome with diarrhea.

Known methods of treatment of drinking mineral waters chronic enteritis, colitis, irritable bowel syndrome (see Reference sanatorium-resort selection. Edited by Bogoliubov V.M., M.: Medicine, 1986; Medical rehabilitation. Edited by Bogoliubov V.M., Moscow-Perm, 1998; Kulikov A.G. // Physiotherapy and balneology. Book II. Ch.5. M., Izd-vo BINOM, 2008. - S-172).

There is a method of treatment of patients with irritable bowel syndrome (see EN NO. 2253465, AK 35/08, OR 1/00, 10.06.2005,), based on the use of bicarbonate-magnesium-calcium-sodium brackish mineral water "Amur-2". The method is used in the complex treatment of functional bowel pathologies and provides drinking mineral water "Amur-2" different temperatures depending on the availability in patients with diarrhea or constipation. However, the method does not involve the carrying out of the stage of adaptation to water treatment that may not contribute to increasing efficiency and reducing treatment time. Comprehensive treatment of mineral water "Amur-2" includes only its internal use.

However, it is known that in the Central region of the Republic of Sa is a (Yakutia), on the territory of Megino-Kangalassky region has a unique mineral waters and therapeutic muds soda lake "Abalach". Abelanski dirt included in the list of most significant used deposits of curative mud Russia (see guidelines of the Ministry of health of the Russian Federation No. 99/228 from 22.12.1999, List of resorts in Russia with the rationale for their unique natural and climatic factors", section 3).

Task to be solved by the claimed invention is directed, is expressed in the increase of efficiency and reduction of terms of treatment of irritable bowel syndrome with diarrhea.

The technical effect obtained by the solution of the problem, expressed in receiving treatment with complex external and internal use of mineral water Deposit Abalaka" (the Republic of Sakha (Yakutia)).

To solve this problem a method of treating irritable bowel syndrome with diarrhea with the use of mineralized sodium bicarbonate mineral water "Abalaka (CA) with a slightly alkaline reaction of the aquatic environment is tailored to the nature of the violations of motor activity of the bowel and acid-forming function of the gastric mucosa and includes thrice daily drinking of CA, duodenal drainage using CA, procedures Kish is knogo irrigation with the use of CA after enemas, procedures tonic coniferous or RPMA baths. This course is a comprehensive treatment is 21 days, including 2 days of inspection of the patient to a course of treatment, 1 day examination after the course of treatment, 18 days treatment with internal and external use of the CA, including drinking water treatment daily for 18 days, duodenal drainage with the CA - 3 treatments, colonic irrigation alternates with toning baths and is 5 treatments irrigation and 10 procedures baths. In addition, disposable drinking dose armature with a temperature of 40-42C gradually increases from 50-80 ml to 200 ml, treatment of duodenal drainage is AMBA, preheated to a temperature of 37-38C in 300 ml single dose treatment of intestinal irrigation is applied armature, preheated to a temperature of 39-40C, while single dose of 500 ml with a subsequent increase to 800 ml.

Comparative analysis of the characteristics of the claimed solution with signs prototype demonstrates compliance of the claimed solution to the criterion "novelty".

Signs of a distinctive part of the formula of the invention provide improved treatment of irritable bowel syndrome with diarrhea, long-term remission, reducing the frequency of relapses and prevent the development of inflammatory processes in the intestinal mucosa.

Mineral is an ode "Abalaka" due to the high content of bicarbonate ions (HCO 3) plays an important role in maintaining acid-alkaline (basic) balance, normalization of the secretory and motor functions of the stomach, biliary tract and intestines, has a pronounced anti-inflammatory effect.

The proposed method is as follows.

When irritable bowel syndrome with diarrhea the patient 21-day comprehensive treatment, including daily 3-course drinking armature with a temperature of 40-42C for 18 days, with a gradual increase in dose with 50-80 ml to 200 ml, 3 procedures duodenal drainage CA (300 ml), the temperature of 37-38C, 10 procedures coniferous or RPMA baths, the temperature of 36-37C with a duration of 12-15 minutes. In alternation with baths is colonic irrigation armature, the temperature To 39-40C, followed by an increase of a single dose of CA from 500 to 800 ml, treatment 5 treatments.

Drinking armature is assigned the first two days 50-80 ml 3 times a day, for 3-4 day single dose of water is increased to 100 ml, 5-6 days - 150 ml from 7 days single dose taken water increases up to one Cup (200 ml). Method and time of reception of the armature is determined by the condition of the secretory function of the stomach. At low secretion of CA introduced for 15-30 minutes before meals, in small SIPS. When saved secretion CA enter for 40-45 minutes prior to a meal, medium SIPS, when raised the Oh secretion - for 1.0-1.5 hours before eating, gulps.

The results of the treatment were evaluated by clinical, laboratory and instrumental diagnostic methods.

The proposed method treated 10 patients with irritable bowel syndrome with diarrhea, including 3 men and 7 women aged 32-53 years.

The diagnosis is verified on the basis of complaints, anamnesis, physical examination, clinical laboratory, instrumental and functional diagnostic methods. Acid-forming function of the stomach was determined by gastric intubation with stimulation limonera. By rektoromanoskopii and colonoscopy were surveyed intestines were conducted fractional duodenal intubation with microscopy of bile. The patients were examined in the dynamics before and after the course of treatment. After carrying out a course of treatment proposed method showed a significant improvement in General condition and well-being of all patients in connection with the normalization of stool frequency and consistency of stool.

The proposed method is illustrated by the following clinical examples.

Example 1. Patient A., aged 45, medical card No. 25, was treated with a diagnosis of irritable bowel syndrome with diarrhea. Seeing a doctor since 1999. If the comprehensive examination on the part of the digestive system pathology it is not revealed. Results the ATA fractional gastric sensing - stored secretory function of the stomach. Complaints of bloating, a feeling of heaviness in the epigastrium, liquid stool, 2 times a day.

The treatment was carried out in accordance with the claimed method. After the examination, the patient is assigned to treatment by drinking mineral water "Abalaka", the temperature of 40-42C. the Recommended three reception armature 45 minutes before a meal 50-80 ml during the first two days. Single dose of CA 3-4 days of treatment was 100 ml, 5-6 days - 150 ml from 7 days single dose taken water increases up to one glass of 200 ml of Water, the patient drank middle SIPS. The course of treatment by drinking 18 days. Patients accepted procedure of duodenal drainage armature temperature of 37-38C, No. 3 (300 ml), procedures coniferous bath temperature of 36-37C with a duration of 12-15 minutes (No. 10), intestinal lavage armature temperature To 39-40C, alternating with the tubs after a cleansing enema (No. 5). Single dose of CA for intestinal irrigation was increased from 500 to 800 ml. of treatment 21 days. Treatment the patient underwent good clinical manifestations of balneology not identified. After the treatment is completely cropped dyspeptic syndromes, normalized stool. Significantly improved patient well-being.

Example 2. Patient T., 33 years, medical card No. 11, was treated with a diagnosis of irritable bowel syndrome is diarrhea. In the study of gastric secretion revealed hipocresia. Complaints of bloating, increased stool frequency to 3-4 times a day, discomfort in the abdomen.

On the background of complex treatment of the patient within 18 days to get mineral water "Abalaka" temperature of 40-42C for 30 minutes before eating slowly, small SIPS 3 times a day for 50-80 ml during the first two days. Single dose of CA 3-4 days of treatment was 100 ml, 5-6 days - 150 ml from 7 days single dose taken water increased to one glass of 200 ml Treatment included procedures duodenal drainage CA 300 ml (No. 3), the temperature of 37-38C, procedures, intestinal irrigation armature with 500 ml to 800 ml (No. 5), the temperature To 39-40C, after enemas, alternating with the RPMA bath temperature of 36-37C, lasting 12-15 minutes (No. 10). The course of treatment is 21 days. After treatment, the patient had no complaints, controlled completely dyspepsia and normal stool consistency.

Thus, therapeutic properties of the CA can be used in gastroenterology and balneology, in particular, in the treatment of irritable bowel syndrome with diarrhea. In addition, the invention is directed to expanding the range of therapeutic mineral waters through the use of local mineral waters in the immediate vicinity of the source.

Method of treatment the Oia irritable bowel syndrome with diarrhea with the use of mineralized sodium bicarbonate mineral water "Abalaka (CA) with a slightly alkaline reaction of the aquatic environment, including thrice daily drinking of CA, duodenal drainage using CA, procedures, intestinal irrigation with the use of CA after enemas, procedures tonic coniferous or RPMA baths; the course of complex treatment is 21 days, including drinking water treatment is 18 days, occasional drinking dose armature temperature of 40-42C gradually increases from 50-80 ml to 200 ml, treatment of duodenal drainage is used armature temperature of 37-38C in a volume of 300 ml single dose treatment of intestinal irrigation armature is preheated up to 39-40C, and single dose of 500 ml increasing to 800 ml, procedures, intestinal irrigation, alternate with baths.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and aims at reducing an abdominal girth in an individual. The bacteria of genus the Bifidobacterium are used. A minimum dose is 1109 CFU a day. Preferentially, the bacteria represent the bacteria of the genus Bifidobacterium animaiis deposed under Nos. CNCM I-2494. The abdominal girth is measured using abdominal inductance plethysmography. The method may be used for treating irritable bowel syndrome.

EFFECT: method enables reducing the abdominal girth, and relieving pain and discomfort caused by an increase thereof.

15 cl, 15 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a composite enterosorbent of a silicone polymer specified in a group containing methyl monosilane acid xerogel or methyl monosilane acid hydrogel, differing by the fact that contains at least one ingredient specified in a group: lactulose, inulin, lignin, fructooligosaccharide, alginic acid in the form of pharmaceutically acceptable salts, chitosan, pectin, gum resin, beta-glucan in the amount of 0.1 to 10 portions per 1 weight portion of monosilane acid hydrogel or xerogel.

EFFECT: invention provides creating an agent to provide normalising the intestinal microflora and relieving the manifesting intoxication.

3 cl, 6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to new 2-S-benzylpyrimidine derivatives having CRTH2 receptor antagonist activity. In formula 1: R1 means -CO2H; R4a and R4b mean hydrogen; W means -C(O)NR7-; R2 and R3, each independently mean F; Cl; Br;-NR10R11 or (C1-C6)alkoxy, optionally substituted by 1-3 halogen atoms; R5 means hydrogen; R6 means (C1-C6)alkyl; (C6-C19)aryl or (5-15)-member heteroaryl containing nitrogen, oxygen or sulphur atoms as heteroatoms, wherein above aryl and heteroaryl are optionally substituted by one or more substitutes specified in a group consisting of halogen; (C1-C6)alkyl optionally substituted by 1-3 halogen atoms; and (C1-C6)alkoxy optionally substituted by one, two or three halogen atoms; R7 means hydrogen; R10 and R11, each independently mean (C1-C6)alkyl; or R10 and R11, together with N, whereto attached form a 3-8- member saturated or unsaturated ring optionally containing one or more O or S atoms, or one or more additional N atoms in the ring; k is equal to 0; m is equal to 1.

EFFECT: invention also refers to using the above compounds for preparing a drug for treating allergic and inflammatory diseases mediated by CRTH2 receptor activity, such as asthma, atopic dermatitis, allergic conjunctivitis, Churg-Strauss disease, sinusitits, basophilic leukaemia, and recurrent urticaria.

27 cl

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to using probiotics in the manufacture of a drug or a therapeutic nutritional composition for long-term prevention of diarrhea in infants. Using the probiotic Lactobacillus rhamnosus ATCC 53103 or Lactobacillus rhamnosus CGMCC 1.3724, and the probiotic Bifidobacterium longum ATCC BAA-999 in the manufacture of a drug or a therapeutic nutritional composition to be introduced into an infant for at least three months for the purpose of long-term prevention of diarrhoea, wherein the probiotic is introduced into a breastfeeding infant from a nursing mother.

EFFECT: using the above probiotic strains from the nursing mother is effective for the purpose of long-term prevention of diarrhoea in infants.

6 cl, 2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, and represents a composite probiotic preparation containing probiotic lactic acid bacilli and bifidus bacteria cells, or mixtures thereof, and a polymer additive in an enterosoluble capsule, differing by the fact that the probiotic lactic acid bacilli and bifidus bacteria cells belong to the species Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, Bifidobacterium longum, while the polymer additive used as a binding agent and being a polysaccharide, is specified in a group: amylopectin, waxy corn starch, native potato starch, soluble potato starch, wheat starch, maltodextrin, or mixtures thereof with the above ingredients of the composite preparation are taken in ratio 108-1012 probiotic lactic acid bacilli and bifidus bacteria cells per 0.01-1 g of the polymer additive.

EFFECT: invention provides creating more effective and stable probiotic preparation for preventing and treating intestinal dysbacterioses and intestinal infections, as well as increasing an ability of the preparation to produce nitrogen monoxide by NO-synthase mechanism.

2 cl, 1 ex, 1 tbl, 5 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to immunology. There are prepared monomer and dimer domains VHH produced of camelids' antibodies able to bind the anti-rotavirus group A antigen VP6, as well as a method of detecting rotavirus group A, a composition for eliciting a passive immunity against rotavirus group A, a vector, cells and a method for producing the domain VHH of the invention, and a immunoassay kit for detecting rotavirus group A.

EFFECT: invention can find further application in preventing and treating rotaviral infections.

14 cl, 7 dwg, 5 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to gastroenterology and represents a method of treating irritable bowel syndrome with constipations with using low-mineralised hydrocarbonate sodium mineral water "Alabakhskaya" (AMW) with a faintly alkaline reaction of the aqueous medium involving the daily three-time drinking of AMW, duodenal drainages with using AMW, intestinal irrigations with using AMW following cleansing enemas, taking toning pine or salt-water baths; the integrated therapeutic course makes 21 day, including an 18-day drinking therapy, a single drinking dose of AMW at temperature 36-38C is gradually increased from 50-80 ml to 200 ml; the duodenal drainage is conducted with using AMW at temperature 37-39C in the amount of 200 ml of a single dose; for intestinal irrigations, AMW is pre-heated to 39-40C, while a single dose makes 500 ml to be gradually increased to 800 ml; the intestinal irrigations are alternated with taking baths.

EFFECT: invention provides higher clinical effectiveness and reduces the length of treatment of irritable bowel syndrome with constipations.

2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and aims at treating irritable bowel syndrome with diarrhoea. The therapy is added with dalargin in a single dose of 0.002 g intramuscularly daily for 10 days running.

EFFECT: method enables reducing the length of the intestinal functional recovery.

3 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely neurology, reflexotherapy. The method comprises the magnetic-laser therapy (MLT), acupuncture and therapeutic exercises (TE) with underlying pharmacotherapy. The MLT involves a paravertebral exposure at wave length 0.88 m, power 10 mW, magnetic field strength 40 mT, 4 minutes on each side alternately. The acupuncture represents another embodiment of the method of inhibition. At first, the acupuncture exposure is contralateral, and starting from the 3rd-5th procedure, the exposure also covers the involved side. All the exercises of each following session are conducted with rate load gain, an increase of the number and extent of the exercises. If observing paresis of the upper extremity, the MLT covers a collar region at the level of interosseus processes of the 5th-6th cervical and thoracic 1st-2nd vertebrae. At first, the acupuncture covers the point (TA) Lan-wei at a healthy ankle of the lower extremity. Starting from the 3rd-5th procedure, the exposure also involves the point Er-jian at a hand of the affected upper extremity. If observing paresis of the lower extremity, the MLT involves the lumbar-sacral region at the level of interosseus processes of the 2nd-3rd lumbar and 1st-2nd sacral vertebrae. Originally, the exposure covers the point Shou-san-li in a forearm of the healthy upper extremity. Starting from the 3rd-5th procedure, another version of the method of excitation is included on the affected side whereat the acupuncture needle is inserted into the point Tsu-syui within a foot of the affected lower extremity. If observing hemiparesis, the MLT includes the collar region at interosseus processes of the 5-6th cervical and 1rd-2nd thoracic vertebrae, then on the lumbosacral region. The exposure includes the point Lan-wei at the healthy ankle of the lower extremity and simultaneously the point Shou-san-li in the forearm of the healthy upper extremity. Starting from the 3rd-5th procedure, the exposure is added with a simultaneous effect on the point Er-jian at the hand of the affected upper extremity and on the point Tsyu-syui at the foot of the affected lower extremity. The physical exercises are combined with the correction of the hand and foot positions. For the purpose of the correction, a trainer extends the fingers and positions them properly in a combination with active-passive flexion and extension of the ankle joint. Treating the locomotor disorders starts 1-7 days after the ischemic stroke has been verified. The therapeutic course consists of 12-15 daily procedures.

EFFECT: method provides higher clinical effectiveness, reduces the length of staying in hospital and the disability rate in the patients.

3 ex, 5 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely gastroenterology, and may be used for treating a patient suffering an inflammatory intestinal disease. That is ensured by administering 5-aminosalicylic acid (5-ASA) in the form of a controlled-release dosage form. The administration involves: a daily dose making approximately 4.8 g of 5-ASA in the form of the controlled-release dosage form taken in portions of 2.4 g of 5-ASA, twice a day for 8 weeks or a shorter period of time enough to achieve a favourable therapeutic effect. The patient represents a patient who has achieved no post-therapeutic remission for approximately 4-8 weeks with using the initial dosage, which involves. A dose of approximately 2.4 g of 5-ASA in the form of a dose of approximately 1.2 g introduced twice a day, in the form of a dose of approximately 2.4 g once a day, or in the form of approximately 0.8 g three times a day. Or a dose of approximately 4.8 g of 5-ASA once a day in the form of a dose of approximately 4.8 g.

EFFECT: invention provides the remission of the disease in a patient after the failed initial course of 5-ASA due to prolonging the therapy and using the dose of 5-ASA in the controlled release form.

2 dwg, 2 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely rehabilitation medicine, physiotherapy and urology and may be used for the purpose of rehabilitation of the patients suffering urolithiasis following lithitripsy. That is ensured by the intake of the herbal tea "Veres" containing wild camomile blossom, knotgrass herb, nosebleed herb and horsetail herb, juniper fruits, sage leaves, birch leaves, red bilberry leaves, linseeds taken in equal proportions. The infusion is taken in a dose of 100 ml 3 times a day 30 minutes before meals for 5-7 preoperative days. The common background therapy follows the lithotripsy procedure. That is combined with the additional intake of the herbal tea "Veres" for 10 days following the above procedure and hydrocarbonate sulphate calcium-magnesium mineral water "Kazachinskaya" of mineralisation 1.44g/l for 24 days following lithotripsy. The mineral water "Kazachinskaya" is taken in a dose of 200-250 ml 3 times a day before meals. Further, after the lithotripsy procedure, a projection of the involved kidneys and renal duct is exposed to the apparatus Bemer-3000 at AC field frequency 30-1000 Hz and magnetic field intensity 8.5-100 mcT. The exposure is generated by an intensive contact applicator from 2 fields in the mode-1 (2-4 stages) of 8 minutes. The therapeutic course makes 10 daily procedures. The background therapy is followed by another one-month intake of the herbal tea "Veres", as well as by another exposure to the apparatus "Bemer-3000" at the same parameters of the electromagnetic field. The contact exposure also covers the kidneys and the lower one-third of the renal duct by means of the intensive application from 2-4 fields in the mode-2 (2-4 stages) of 12 minutes. The exposure is daily, two times a day.

EFFECT: method provides reducing the length of calculus fragments discharge following the lithotripsy procedure, improving the clinical and biochemical blood and urine statuses, renal blood flow, treating and preventing the postoperative complications, recovering the immunological responsiveness and antioxidant protection.

4 dwg, 3 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to gastroenterology and represents a method of treating irritable bowel syndrome with constipations with using low-mineralised hydrocarbonate sodium mineral water "Alabakhskaya" (AMW) with a faintly alkaline reaction of the aqueous medium involving the daily three-time drinking of AMW, duodenal drainages with using AMW, intestinal irrigations with using AMW following cleansing enemas, taking toning pine or salt-water baths; the integrated therapeutic course makes 21 day, including an 18-day drinking therapy, a single drinking dose of AMW at temperature 36-38C is gradually increased from 50-80 ml to 200 ml; the duodenal drainage is conducted with using AMW at temperature 37-39C in the amount of 200 ml of a single dose; for intestinal irrigations, AMW is pre-heated to 39-40C, while a single dose makes 500 ml to be gradually increased to 800 ml; the intestinal irrigations are alternated with taking baths.

EFFECT: invention provides higher clinical effectiveness and reduces the length of treatment of irritable bowel syndrome with constipations.

2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine and aims at treating bile passage dysfunction. What is involved is a 2-staged integrated treatment. At the 1st stage, a diet, sorbents, mineral water, physiotherapy (thermal vibromassage of the area of the gall bladder and liver, or biologically active points) are prescribed. At the 2nd stage, the treatment is prolonged by administering adsorbents in the form of herbal preparations, as well as pelotherapy considering a type of dysfunction.

EFFECT: method enables reducing the length of pain management, prolonging remission or achieving full rehabilitation in children and adolescents suffering bile passage dysfunction and living in environmentally unfriendly regions.

3 cl, 4 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to physiotherapy, gastroenterology. The method involves dietary therapy No. 5, general pine baths, magnetic laser therapy, intake of mineral water with underlying sparing training regimen followed by transverse galvanisation of the epigastrial area. The transverse galvanisation immediately follows the intake of mineral water between 10 to 11 o'clock. Additionally, the right hypochondrium and sternum are exposed to EHF radiation generated by a broadband noise transducer with a frequency of 40-63 GHz, for 10 minutes per each area, every day; the therapeutic course is 10-12 procedures.

EFFECT: method enables higher clinical effectiveness ensured by using a chronobiological approach to treating the patients for the purpose of relieving the functional disorders of the bile system with underlying increased adaptive capacities of the body.

2 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely - to dermatology, physiotherapy. The method includes taking mineral baths with mineral water of Annensk deposit of the Khabarovsk Territory and joint mud therapy. Additional, the patient intakes mineral water 100 - 200 ml, 3 times a day 30 minutes before meals. The baths are taken once a day at temperature 37 - 38C, for 10-20 minutes. The therapeutic course includes 10-14 baths. The joint mud therapy is performed by applying low-mineralised low-sulphide silt mud on the affected joints. The mud therapy is performed two days running with a one-day pause. The therapeutic course is 6-10 procedures. After the therapeutic course is completed, the affected joints are coated with Relyct gel for 1.0 - 1.5 months dissolved in mineral water.

EFFECT: method prolongs the length of the intercurrent period.

3 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely balneology, physiotherapy. A method involves intake of mineral water, bath taking, small herbal enemas, mineral water siphonages and thermotherapy. Low-mineral carbonate hydrocarbonate-sulphate sodium-calcium mineral water 3.6-3.7 g/l is taken in the amount of 3-5 ml per one kg of body weight 3 times a day 40-45 minute before meals. Same mineral water is used for bath taking at temperature 36-37C for 15 minutes, 8 procedures every second day. Small herbal enemas are prescribed every second day; the therapeutic course is 8 procedures. Mineral water siphonages are prescribed in number of 3-4 procedures within the therapeutic course. The thermal therapy includes preventative mini-sauna "Cedar Spa" every second day within the therapeutic course of 10 procedures.

EFFECT: method provides higher clinical effectiveness ensured by relieving manifestations of metabolic syndrome, increasing a testosterone level, normalising lipid metabolism.

3 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and aims at treating irritable bowel syndrome. What is used is a low-mineralised sodium hydrocarbonate Abalakhskaya mineral water (AMW) with an faintly alkaline reaction of aqueous medium. The complex therapeutic course makes 21 days including drinking therapy - 18 days, a single drinking dose of AMW of temperature 38-40C is gradually increased from 50-80 ml to 180-200 ml; the procedures of duodenal drainage are performed with the use of AMW of temperature 37-38C in the amount of 200 ml of a single dose; for the procedures of intestinal irrigations, AMW is pre-heated to 40-42C, while a single dose makes 500 ml gradually increased to 800 ml; the procedures of intestinal irrigations are alternated with baths.

EFFECT: method provides higher clinical effectiveness in irritable bowel syndrome, normalised intestinal motility.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, gastroenterology. Method includes dietotherapy in accordance with diet No 5, exercise therapy. Additionally intake of low-mineralised carbonaceous chloride-hydrocarbonate-sulfate-sodium-calcium mineral water "Essentuki-Novaya" is realised. Water is taken in in dose 3.5 ml per 1 kg of patient's body weight, 3 times per day, 30-40 minutes before meal. Carbonaceous-hydrogen sulfide mineral baths with content of hydrogen sulfide 15-20 mg/l are carried out every second day. Baths are taken with water temperature 36-37C. Course includes 8-10 procedures. Dalargin magnetophoresis on liver projection is performed daily. Pulsing travelling magnetic field from apparatus AMO-ATOS is used. Magnetophoresis is carried out with induction 45 mT, with modulation frequency 10 Hz for 15 minutes, course includes 10 procedures.

EFFECT: method reduces treatment terms and increases its efficiency due to normalisation of oxidative homeostasis, improvement of functional state of liver and lipid metabolism.

2 ex, 4 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to balneology. Method includes taking baths with mineral water of thermal radon springs with water temperature about 38C. Baths are taken two days running with a day break after them. The first procedure lasts 3 minutes, the second procedure lasts 5 minutes. The following procedures last 8 minutes. Treatment is carried out at the background No 8 diet. Patient drinks 100 ml of radon water in the first part of the day, two hours after breakfast. Swimming in a swimming pool is performed for 40 minutes. After that detensor-therapy is carries out. In the second half of the day patient drinks 100 ml of radon water two hours after dinner, then takes a bath with radon water. After that, procedure by programme of resonance-acoustic fluctuations (PRAF) is carried out, followed by swimming in a swimming pool for 40 minutes. On days when there are no baths intestinal lavage is performed in the first half of the day, with 40-minute long swimming in a swimming pool in the second half.

EFFECT: method increases treatment efficiency due to complex impact on organism, providing improvement of tissue trophism, microcirculation, metabolism in affected extremities, increasing tone in lymphatic vessels, improving lymph outflow.

3 cl, 2 tbl

FIELD: medicine.

SUBSTANCE: formulation for treating patients with urolithiasis which contains an active ingredient presented by a mixture of saturated and unsaturated aliphatic hydrocarbons C10-C24 recovered from mineral water of Munok pool situated in Kazachinskiy-Lenskiy area of the Irkutsk Region (source No. 17), a stabilising agent - ethanol and water in certain qualitative and quantitative proportions.

EFFECT: formulation is effective for treating urolithiasis.

FIELD: medicinal microbiology, medicine, pharmacy.

SUBSTANCE: invention relates to agents used for enhancing sensitivity of microorganisms to antibacterial preparations. Invention involves applying hydrocarbonate chloride-sodium drinking mineral water "Obukhovskaya" with the total mineralization 1.8-2.2 g/l as an agent for enhancing sensitivity of microorganisms to antibacterial preparations that is used early for treatment of atopic dermatitis and as an agent for treatment of iodine-deficient states. It has been found by method using disks that mineral water "Obukhovskaya" provides enhancing sensitivity of microorganisms to such antibacterial preparations as antibiotics and specific preparations against yeast-like fungi.

EFFECT: improved and valuable agent.

6 tbl, 6 ex

Up!